ストックスクリーナーアプリを入手
0.0801
11.25%
0.0081
前日終値:
$0.072
開ける：
$0.075
24時間の取引高:
45,564
Relative Volume:
1.89
時価総額：
$N/A
収益：
$7.33M
当期純損益:
$-21.20M
株価収益率:
-0.0876
EPS:
-0.9143
ネットキャッシュフロー:
$-12.68M
1週間 パフォーマンス:
+11.25%
1か月 パフォーマンス:
-86.71%
6か月 パフォーマンス:
-95.33%
1年 パフォーマンス:
-96.64%
1日の値動き範囲:
$0.075
$0.0949
1週間の範囲:
$0.075
$0.0949
52週間の値動き範囲:
$0.07
$0.105
Prophase Labs Inc Stock (PRPH) Company Profile
Compare PRPH vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.0801 | 0 | 7.33M | -21.20M | -12.68M | -0.9143 |
TMO
Thermo Fisher Scientific Inc
|
488.19 | 181.35B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.12 | 135.96B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
577.44 | 45.86B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.84 | 32.45B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.09 | 29.83B | 3.17B | 642.63M | 516.49M | 10.77 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-20 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-13 | ダウングレード | Dawson James | Buy → Neutral |
| 2021-01-20 | 開始されました | Dawson James | Buy |
Prophase Labs Inc (PRPH) 最新ニュース
ProPhase Labs (NASDAQ:PRPH) versus Medicure (OTCMKTS:MCUJF) Financial Contrast - Defense World
ProPhase Labs, Inc. (PRPH) stock price, news, quote and history - Yahoo Finance UK
Risk Hedge: Is ProPhase Labs Inc exposed to political risk2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
Quarterly Risk: How does ProPhase Labs Inc score in quality rankings2026 Trading Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
ProPhase Labs Delays Annual 10-K Yearly Filing - TipRanks
ProPhase Labs (PRPH) notifies SEC of delayed FY2025 10-K; expects 15-day filing - Stock Titan
Guidance Update: Is ProPhase Labs Inc exposed to political risk2026 Snapshot & Weekly High Return Opportunities - baoquankhu1.vn
Trend Recap: What analysts say about ProPhase Labs Inc stockIndex Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Investment Recap: How much upside does ProPhase Labs Inc have2026 Macro Impact & Verified Entry Point Detection - baoquankhu1.vn
Gains Report: What analysts say about ProPhase Labs Inc stockQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
ProPhase Labs (PRPH) Updates on Crown Medical Collections Progre - GuruFocus
ProPhase Labs provides business update highlighting advancing Crown Medical collections activity - marketscreener.com
ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity - The Manila Times
Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity - TradingView
Biotech seeks insurer recoveries from 250+ payors for receivables-backed cash - Stock Titan
Big Picture: What analysts say about ProPhase Labs Inc stockQuarterly Growth Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Financial Analysis: ProPhase Labs (NASDAQ:PRPH) versus Ono Pharmaceutical (OTCMKTS:OPHLF) - Defense World
Aug Swings: How correlated is ProPhase Labs Inc to the S P500Earnings Overview Summary & Verified Short-Term Plans - baoquankhu1.vn
Short Covering: What analysts say about ProPhase Labs Inc stockVolume Spike & Long-Term Investment Growth Plans - baoquankhu1.vn
Guidance Update: Whats next for ProPhase Labs Inc stockJuly 2025 Final Week & Precise Buy Zone Identification - baoquankhu1.vn
Will ProPhase Labs Inc outperform the market in YEAR2025 AllTime Highs & Low Risk Entry Point Guides - baoquankhu1.vn
Head-To-Head Review: ProPhase Labs (NASDAQ:PRPH) & Enliven Therapeutics (NASDAQ:ELVN) - Defense World
PRPH SEC FilingsProphase Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ProPhase Labs Hosts Investor Webinar on Growth Portfolio - TipRanks
ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative - Yahoo Finance
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd - GlobeNewswire
ProPhase Labs Issues Update on Crown Medical Collections - TipRanks
ProPhase Labs (PRPH) Provides Update on COVID-19 Receivables Col - GuruFocus
ProPhase Labs Secures Funding and Completes Market Transition Following Reverse Stock Split - AD HOC NEWS
ProPhase Labs enters $10 million equity line agreement with Generating Alpha - Investing.com
Off the Pink Sheets: ProPhase Labs shifts to OTC market - Stock Titan
Prophase Labs Approves Strategic Proposals at Special Meeting - MSN
ProPhase Labs, Inc.Common Stock (NQ: PRPH - FinancialContent
ProPhase Labs Updates Shareholders Amid Volatility and OTC Move - TipRanks
ProPhase Labs Announces Immediate Resignation of Board Member - TipRanks
ProPhase Labs Announces Board Resignation - TradingView — Track All Markets
Is ProPhase Labs Inc. stock a safe haven asset2025 Pullback Review & Weekly Watchlist of Top Performers - ulpravda.ru
How ProPhase Labs Inc. stock compares to market leadersCEO Change & Low Drawdown Trading Techniques - ulpravda.ru
How strong is ProPhase Labs Inc. stock balance sheetLayoff News & Community Verified Trade Signals - ulpravda.ru
Will ProPhase Labs Inc. stock outperform Nasdaq indexEarnings Overview Report & AI Driven Stock Reports - ulpravda.ru
MSN Money - MSN
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Total liabilities of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Cash from investing activities of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
ProPhase Labs faces NASDAQ delisting, plans appeal, OTC move - MSN
ProPhase Labs, Inc.(NasdaqCM: PRPH) dropped from S&P TMI Index - marketscreener.com
ProPhase Labs, Inc. Balance Sheet – OTC:PRPH - TradingView — Track All Markets
Free cash flow per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Long term debt to total assets ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Net margin % of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Prophase Labs Inc (PRPH) 財務データ
収益
当期純利益
現金流量
EPS
0.47%
1.47%
大文字化:
|
ボリューム (24 時間):